EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Triple Negative Breast Cancer With Choroidal Metastasis Responsive to Sacituzumab Govitecan and Radiation Therapy

Nellie Nafissi iD, Aditya Mahadevan iD, Elaine Chiao iD, Nejina Rijal, Ritesh Parajuli iD

Cancer Reports · 2026

DOI: 10.1002/cnr2.70462 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cancer Reports, 2026. Verfasst von Nellie Nafissi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, University of California Irvine Health, Orange, California, USA. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Choroid Neoplasms, Antibodies, Monoclonal, Humanized, Immunoconjugates. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Orbital metastases are rare in patients with breast cancer. However, medical management of orbital metastases is limited by the inability of treatment options to penetrate the blood‐brain barrier. In patients with triple negative breast cancer (TNBC), these treatment options are further limited. Sacituzumab govitecan, an antibody‐drug conjugate, has emerged as a promising agent for metastatic TNBC. However, to date, patients with central nervous system (CNS) disease have been excluded from corresponding clinical trials, making the efficacy of sacituzumab govitecan in patients with orbital metastases unclear. Case A 61‐year‐old female was initially diagnosed with a left breast hormone receptor positive invasive ductal carcinoma, receiving neoadjuvant chemotherapy with doxorubicin, cyclophosphamide, and docetaxel and a partial mastectomy. Several years later, the patient presented with a cough and was subsequently diagnosed with metastatic triple negative breast cancer with hepatic, osseous, and right supraclavicular and thoracic nodal metastases. Concurrently, the patient noted floaters in her vision, later found to be consistent with orbital metastases. The patient received radiation therapy to both eyes and was started on Sacituzumab govitecan. Following cycle 1, the ophthalmic exam showed a dramatic decrease in the size of choroidal metastases.

Conclusion

This case report documents the first case of orbital metastases successfully treated with radiation therapy and sacituzumab govitecan. As such, this case highlights the importance of sacituzumab govitecan as a potentially effective option for TNBC patients with CNS disease. Further studies and real‐world data are needed to investigate the efficacy of combined radiotherapy and sacituzumab govitecan toward ocular metastases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsChoroid NeoplasmsAntibodies, Monoclonal, HumanizedImmunoconjugatesCarcinoma, Ductal, BreastHumansFemaleMiddle AgedAntineoplastic Combined Chemotherapy ProtocolsCamptothecin

Substanzen

sacituzumab govitecanAntibodies, Monoclonal, HumanizedImmunoconjugatesCamptothecin

Autor:innen und Institutionen

  • Division of Hematology/Oncology, University of California Irvine Health, Orange, California, USA.
  • Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Department of Medicine, University of California Los Angeles, Los Angeles, California, USA.

ORCID-Profile: Nellie Nafissi, Aditya Mahadevan, Elaine Chiao, Ritesh Parajuli

Zitieren

APA

Nafissi, N., Mahadevan, A., Chiao, E., Rijal, N., & Parajuli, R. (2026). Triple Negative Breast Cancer With Choroidal Metastasis Responsive to Sacituzumab Govitecan and Radiation Therapy. Cancer Reports. https://doi.org/10.1002/cnr2.70462

Vancouver

Nafissi N, Mahadevan A, Chiao E, Rijal N, Parajuli R. Triple Negative Breast Cancer With Choroidal Metastasis Responsive to Sacituzumab Govitecan and Radiation Therapy. Cancer Reports. 2026. doi:10.1002/cnr2.70462

BibTeX
@article{Nafissi2026,
  author = {Nafissi, Nellie and Mahadevan, Aditya and Chiao, Elaine and Rijal, Nejina and Parajuli, Ritesh},
  title = {Triple Negative Breast Cancer With Choroidal Metastasis Responsive to Sacituzumab Govitecan and Radiation Therapy},
  journal = {Cancer Reports},
  year = {2026},
  doi = {10.1002/cnr2.70462}
}
Kostenlos starten →